BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15986292)

  • 1. [Primary sclerosing cholangitis is a premalignant condition].
    Schramm C; Galle PR
    Z Gastroenterol; 2005 Jun; 43(6):607-11. PubMed ID: 15986292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of dominant stenoses on the serum level of the tumor marker CA19-9 in patients with primary sclerosing cholangitis.
    Petersen-Benz C; Stiehl A
    Z Gastroenterol; 2005 Jun; 43(6):587-90. PubMed ID: 15986288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy.
    Weismüller TJ; Wedemeyer J; Kubicka S; Strassburg CP; Manns MP
    J Hepatol; 2008; 48 Suppl 1():S38-57. PubMed ID: 18304683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on primary sclerosing cholangitis.
    Maggs JR; Chapman RW
    Curr Opin Gastroenterol; 2008 May; 24(3):377-83. PubMed ID: 18408468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary sclerosing cholangitis.
    Rodriguez HJ; Bass NM
    Semin Gastrointest Dis; 2003 Oct; 14(4):189-98. PubMed ID: 14719769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary dysplasia in patients with primary sclerosing cholangitis: additional value of DNA ploidity.
    Halme L; Arola J; Numminen K; Krogerus L; Mäkisalo H; Färkkilä M
    Liver Int; 2012 May; 32(5):783-9. PubMed ID: 22098817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis.
    Tischendorf JJ; Meier PN; Strassburg CP; Klempnauer J; Hecker H; Manns MP; Krüger M
    Scand J Gastroenterol; 2006 Oct; 41(10):1227-34. PubMed ID: 16990210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary sclerosing cholangitis].
    Boonstra K; Ponsioen CI; Rauws EA; Beuers U
    Ned Tijdschr Geneeskd; 2010; 154():A1476. PubMed ID: 20619015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma.
    Koopmann J; Thuluvath PJ; Zahurak ML; Kristiansen TZ; Pandey A; Schulick R; Argani P; Hidalgo M; Iacobelli S; Goggins M; Maitra A
    Cancer; 2004 Oct; 101(7):1609-15. PubMed ID: 15378479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary sclerosing cholangitis: a clinical update.
    Williamson KD; Chapman RW
    Br Med Bull; 2015 Jun; 114(1):53-64. PubMed ID: 25981516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary sclerosing cholangitis--diagnosis and therapy].
    Virović L; Supanc V; Duvnjak M
    Acta Med Croatica; 2003; 57(3):207-19. PubMed ID: 14582467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary sclerosing cholangitis: a clinical review.
    Ponsioen CI; Tytgat GN
    Am J Gastroenterol; 1998 Apr; 93(4):515-23. PubMed ID: 9576440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy.
    Brandsaeter B; Isoniemi H; Broomé U; Olausson M; Bäckman L; Hansen B; Schrumpf E; Oksanen A; Ericzon BG; Höckerstedt K; Mäkisalo H; Kirkegaard P; Friman S; Bjøro K
    J Hepatol; 2004 May; 40(5):815-22. PubMed ID: 15094230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
    Terg R; Sambuelli A; Coronel E; Mazzuco J; Cartier M; Negreira S; Muñoz A; Gil A; Miguez C; Huernos S; Romero G; Goncalvez S; Levi D; Abecasis R
    Acta Gastroenterol Latinoam; 2008 Mar; 38(1):26-33. PubMed ID: 18533354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerosing cholangitis.
    MacFaul GR; Chapman RW
    Curr Opin Gastroenterol; 2006 May; 22(3):288-93. PubMed ID: 16550044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary sclerosing cholangitis.
    Geonzon-Gonzales MR
    Gastroenterol Nurs; 2007; 30(2):102-5; quiz 105-7. PubMed ID: 17440311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary sclerosing cholangitis: new approaches to diagnosis, surveillance and treatment.
    Trauner M; Halilbasic E; Baghdasaryan A; Moustafa T; Krones E; Fickert P; Hofer H; Penner E
    Dig Dis; 2012; 30 Suppl 1():39-47. PubMed ID: 23075867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
    Broomé U; Bergquist A
    Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.